Literature DB >> 22552731

Impairment of adenylyl cyclase 2 function and expression in hypoxanthine phosphoribosyltransferase-deficient rat B103 neuroblastoma cells as model for Lesch-Nyhan disease: BODIPY-forskolin as pharmacological tool.

Liz Kinast1, Juliane von der Ohe, Heike Burhenne, Roland Seifert.   

Abstract

Hypoxanthine phosphoribosyl transferase (HPRT) deficiency results in Lesch-Nyhan disease (LND). The link between the HPRT defect and the self-injurious behavior in LND is still unknown. HPRT-deficient rat B103 neuroblastoma cells serve as a model system for LND. In B103 cell membranes, HPRT deficiency is associated with a decrease of basal and guanosine triphosphate-stimulated adenylyl cyclase (AC) activity (Pinto and Seifert, J Neurochem 96:454-459, 2006). Since recombinant AC2 possesses a high basal activity, we tested the hypothesis that AC2 function and expression is impaired in HPRT deficiency. We examined AC regulation in B103 cell membranes, cAMP accumulation in intact B103 cells, AC isoform expression, and performed morphological studies. As most important pharmacological tool, we used 4,4-difluoro-4-bora-3a,4a-diaza-s-indacene forskolin (BODIPY-FS) that inhibits recombinant AC2 but activates ACs 1 and 5 (Erdorf et al., Biochem Pharmacol 82:1673-1681, 2011). In B103 control membranes, BODIPY-FS reduced catalysis, but in HPRT(-) membranes, BODIPY-FS was rather stimulatory. 2'(3')-O-(N-methylanthraniloyl) (MANT)-nucleoside 5'-[γ-thio]triphosphates inhibit recombinant ACs 1 and 5 more potently than AC2. In B103 control membranes, MANT-guanosine 5'-[γ-thio]triphosphate inhibited catalysis in control membranes less potently than in HPRT(-) membranes. Quantitative real-time PCR revealed that in HPRT deficiency, AC2 was virtually absent. In contrast, AC5 was up-regulated. Forskolin (FS) and BODIPY-FS induced cell clustering and rounding and neurite extension in B103 cells. The effects of FS and BODIPY-FS were much more prominent in control than in HPRT(-) cells, indicative for a differentiation defect in HPRT deficiency. Neither FS nor BODIPY-FS significantly changed cAMP concentrations in intact B103 cells. Collectively, our data show that HPRT deficiency in B103 cells is associated with impaired AC2 function and expression and reduced sensitivity to differentiation induced by FS and BODIPY-FS. We discuss the pathophysiological implications of our data for LND.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22552731     DOI: 10.1007/s00210-012-0759-6

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  77 in total

Review 1.  Tissue specificity and physiological relevance of various isoforms of adenylyl cyclase.

Authors:  N Defer; M Best-Belpomme; J Hanoune
Journal:  Am J Physiol Renal Physiol       Date:  2000-09

2.  GDP affinity and order state of the catalytic site are critical for function of xanthine nucleotide-selective Galphas proteins.

Authors:  Andreas Gille; Katharina Wenzel-Seifert; Michael B Doughty; Roland Seifert
Journal:  J Biol Chem       Date:  2002-12-23       Impact factor: 5.157

3.  Methylmercury genotoxicity: a novel effect in human cell lines of the central nervous system.

Authors:  María Elena Crespo-López; Andréa Lima de Sá; Anderson Manoel Herculano; Rommel Rodríguez Burbano; José Luiz Martins do Nascimento
Journal:  Environ Int       Date:  2006-09-26       Impact factor: 9.621

4.  Hypoxanthine impairs morphogenesis and enhances proliferation of a neuroblastoma model of Lesch Nyhan syndrome.

Authors:  M H Ma; N C Stacey; G P Connolly
Journal:  J Neurosci Res       Date:  2001-03-15       Impact factor: 4.164

Review 5.  Update on the phenotypic spectrum of Lesch-Nyhan disease and its attenuated variants.

Authors:  Rosa J Torres; Juan G Puig; H A Jinnah
Journal:  Curr Rheumatol Rep       Date:  2012-04       Impact factor: 4.592

6.  Motor dysfunction in type 5 adenylyl cyclase-null mice.

Authors:  Tamio Iwamoto; Satoshi Okumura; Kousaku Iwatsubo; Jun-Ichi Kawabe; Koji Ohtsu; Ikuko Sakai; Yoko Hashimoto; Aki Izumitani; Kazunori Sango; Kyoko Ajiki; Yoshiyuki Toya; Satoshi Umemura; Yoshio Goshima; Nobutaka Arai; Stephen F Vatner; Yoshihiro Ishikawa
Journal:  J Biol Chem       Date:  2003-03-28       Impact factor: 5.157

7.  Protein tyrosine phosphatase receptor type Z is involved in hippocampus-dependent memory formation through dephosphorylation at Y1105 on p190 RhoGAP.

Authors:  Hiroshi Tamura; Masahide Fukada; Akihiro Fujikawa; Masaharu Noda
Journal:  Neurosci Lett       Date:  2006-02-28       Impact factor: 3.046

Review 8.  Forskolin: a specific stimulator of adenylyl cyclase or a diterpene with multiple sites of action?

Authors:  A Laurenza; E M Sutkowski; K B Seamon
Journal:  Trends Pharmacol Sci       Date:  1989-11       Impact factor: 14.819

9.  Effects of age and spatial learning on adenylyl cyclase mRNA expression in the mouse hippocampus.

Authors:  N Mons; L Segu; X Nogues; M C Buhot
Journal:  Neurobiol Aging       Date:  2004-09       Impact factor: 4.673

10.  Tissue-specific aberrations of gene expression in HPRT-deficient mice: functional complexity in a monogenic disease?

Authors:  Shaochun Song; Theodore Friedmann
Journal:  Mol Ther       Date:  2007-05-15       Impact factor: 11.454

View more
  9 in total

1.  A door opener for future research: agonist-induced β3-adrenoceptor desensitization in HEK cells but not CHO cells.

Authors:  Roland Seifert
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2013-06-12       Impact factor: 3.000

2.  Naunyn-Schmiedeberg's Archives of Pharmacology under new editorship: change and continuity.

Authors:  Roland Seifert
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2016-05-24       Impact factor: 3.000

Review 3.  International Union of Basic and Clinical Pharmacology. CI. Structures and Small Molecule Modulators of Mammalian Adenylyl Cyclases.

Authors:  Carmen W Dessauer; Val J Watts; Rennolds S Ostrom; Marco Conti; Stefan Dove; Roland Seifert
Journal:  Pharmacol Rev       Date:  2017-04       Impact factor: 25.468

4.  Report on the Third Symposium "cCMP and cUMP as New Second Messengers".

Authors:  Erich H Schneider; Roland Seifert
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2014-12-04       Impact factor: 3.000

5.  Consequences of impaired purine recycling on the proteome in a cellular model of Lesch-Nyhan disease.

Authors:  Eric B Dammer; Martin Göttle; Duc M Duong; John Hanfelt; Nicholas T Seyfried; H A Jinnah
Journal:  Mol Genet Metab       Date:  2015-03-05       Impact factor: 4.797

6.  Agonist-induced desensitization of human β3-adrenoceptors expressed in human embryonic kidney cells.

Authors:  Martina B Michel-Reher; Martin C Michel
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2013-06-12       Impact factor: 3.000

Review 7.  Physiological roles of mammalian transmembrane adenylyl cyclase isoforms.

Authors:  Katrina F Ostrom; Justin E LaVigne; Tarsis F Brust; Roland Seifert; Carmen W Dessauer; Val J Watts; Rennolds S Ostrom
Journal:  Physiol Rev       Date:  2021-10-26       Impact factor: 37.312

8.  Dissociations in the effects of β2-adrenergic receptor agonists on cAMP formation and superoxide production in human neutrophils: support for the concept of functional selectivity.

Authors:  Irena Brunskole Hummel; Michael T Reinartz; Solveig Kälble; Heike Burhenne; Frank Schwede; Armin Buschauer; Roland Seifert
Journal:  PLoS One       Date:  2013-05-31       Impact factor: 3.240

9.  HPRT-deficiency dysregulates cAMP-PKA signaling and phosphodiesterase 10A expression: mechanistic insight and potential target for Lesch-Nyhan Disease?

Authors:  Ghiabe-Henri Guibinga; Fiona Murray; Nikki Barron
Journal:  PLoS One       Date:  2013-05-14       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.